Clinical Trial

Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)

Study acronym: BTCP
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The general objective of this split-mouth study is to analyze the osteogenic action of BTCP during the bone regeneration process following the extraction of impacted mandibular third molars.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-13.
Trial Details
NCT Number NCT06935747
Lead Sponsor Mario Pérez Sayáns
Collaborators: Universidad de Murcia, Nueva Galimplant SLU
Conditions Bone Loss, Regenerative Inflammation, Third Molars Extraction
Enrollment 30 participants
Start Date 2025-07
Primary Completion 2026-03 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-04-24